Related Experiment Video
Updated: May 11, 2026

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
Published on: October 6, 2014
Deficiency of caveolin-1 in Apc(min/+) mice promotes colorectal tumorigenesis
Teresa Friedrich1, Birgit Richter, Timo Gaiser
1Department of Internal Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, D-68167 Mannheim, Germany.
Abstract:
Caveolin-1 (Cav1), a scaffold protein of membrane caveolae and coactivator of peroxisome proliferator-activated receptor gamma (PPARg), inhibits oncogenic signaling through Ras and wingless. However, the in vivo role of Cav1 in colorectal cancer (CRC) remained unknown. To test whether loss of Cav1 accelerates tumorigenesis, we generated a novel mouse model of CRC by crossing C57BL/6 Apc(min/+) with B6129 Cav1 knockout (Cav1-/-) mice. Apc(min/+) Cav1-/- mice developed large, microinvasive and vascularized intraepithelial adenocarcinomas in the distal colon and rectum with higher incidence than Apc(min/+) Cav1+/- and Apc(min/+) Cav1+/+ littermates. Intratumoral gene signatures related to Ras and wingless signaling were elevated, nuclear localization of PPARg protein and expression of PPARg-target genes were reduced independently of Cav1. The PPARg-agonist rosiglitazone prevented tumor formation in mice irrespectively of the Cav1 status and upregulated expression of the Ras-inhibitory protein docking protein-1. Thus, codeficiency of Cav1 and adenomatous polyposis coli facilitated formation of CRC, and activation of PPARg may offer novel strategies for treatment of CRC.
Insights
Loss of Caveolin-1 (Cav1) accelerates colorectal cancer (CRC) development in mice. Activating PPARg may offer new CRC treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Caveolin-1 (Cav1) is a protein involved in cell signaling pathways.
- Cav1's role in colorectal cancer (CRC) tumorigenesis in vivo was previously unknown.
Purpose of the Study:
- To investigate the in vivo role of Cav1 in colorectal cancer (CRC).
- To determine if Cav1 deficiency accelerates CRC development.
Main Methods:
- Generated a novel mouse model by crossing Apc(min/+) mice with Cav1 knockout (Cav1-/-) mice.
- Analyzed tumor incidence and characteristics in Apc(min/+) Cav1-/- mice compared to controls.
- Examined gene expression and protein localization related to Ras, wingless, and PPARg signaling.
Main Results:
- Apc(min/+) Cav1-/- mice exhibited a higher incidence of large, invasive adenocarcinomas in the distal colon and rectum.
- Intratumoral Ras and wingless signaling were elevated, while PPARg activity was reduced.
- The PPARg-agonist rosiglitazone inhibited tumor formation regardless of Cav1 status and increased expression of docking protein-1.
Conclusions:
- Co-deficiency of Cav1 and adenomatous polyposis coli facilitates CRC formation.
- PPARg activation presents a potential therapeutic strategy for colorectal cancer treatment.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Hedgehog Signaling Pathway
Anaphase Promoting Complex
Canonical Wnt Signaling Pathway

